Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro.
- Authors
- Lieberman, Richard; Levine, Eric S; Kranzler, Henry R; Abreu, Christine; Covault, Jonathan
- Year
- 2012
- Journal
- Alcoholism, clinical and experimental research
- PMID
- 22486492
- DOI
- 10.1111/j.1530-0277.2012.01792.x
- PMCID
- PMC3424319
BACKGROUND: Studies of the effects of alcohol on N-methyl-d-aspartate (NMDA) receptor function and gene expression have depended on rodent or postmortem human brain models. Ideally, the effects of alcohol might better be examined in living neural tissue derived from human subjects. In this study, we used new technologies to reprogram human subject-specific tissue into pluripotent cell colonies and generate human neural cultures as a model system to examine the molecular actions of alcohol. METHODS: Induced pluripotent stem (iPS) cells were generated from skin biopsies taken from 7 individuals, 4 alcohol-dependent subjects, and 3 social drinkers. We differentiated the iPS cells into neural cultures and characterized them by immunocytochemistry using antibodies for the neuronal marker beta-III tubulin, glial marker s100β, and synaptic marker synpasin-1. Electrophysiology was performed to characterize the iPS-derived neurons and to measure the effects of acute alcohol exposure on the NMDA receptor response in chronically alcohol exposed and nonexposed neural cultures from 1 nonalcoholic. Finally, we examined changes in mRNA expression of the NMDA receptor subunit genes GRIN1, GRIN2A, GRIN2B, and GRIN2D after 7 days of alcohol exposure and after 24-hour withdrawal from chronic alcohol exposure. RESULTS: Immunocytochemistry revealed positive staining for neuronal, glial, and synaptic markers. iPS-derived neurons displayed spontaneous electrical properties and functional ionotropic receptors. Acute alcohol exposure significantly attenuated the NMDA response, an effect that was not observed after 7 days of chronic alcohol exposure. After 7 days of chronic alcohol exposure, there were significant increases in mRNA expression of GRIN1, GRIN2A, and GRIN2D in cultures derived from alcoholic subjects but not in cultures derived from nonalcoholics. CONCLUSIONS: These findings support the potential utility of human iPS-derived neural cultures as in vitro models to examine the molecular actions of alcohol on human neural cells.
Neural Differentiation Timeline(A) Timeline of neural differentiation includes culturing iPS cell colonies (B) to confluency for 7 days, followed by culture in suspension for 4 days to allow for the formation of embryoid bodies, followed by incubation in neural induction media and growth on a laminin substrate to trigger the formation of neuroepithelial cells displaying neural tube-like rosette structures, which are expanded in suspension (C) culture for several days prior to plating dissociated cells on coverslips. Dissociated cells are cultured in a neural differentiation media containing the growth factors BDNF, GDNF, and IGF to promote the differentiation of neural cells (D, arrows indicate neural cell bodies, red arrow indicates recording electrode for performing electrophysiology). Dissociated neural cells were then cultured for 12–18 weeks in neural differentiation media. At 10-weeks post-plating neural cultures displayed neuronal lineage marker beta III-tubulin and glial cell lineage s100β positive cells (E), indicating that iPS cells differentiated into cultures containing a mixed culture of neurons and glia. Focal synapsin-1 immunostaining along beta III tubulin (F) positive processes were observed indicating the formation of synaptic specializations within the culture.
Electrophysiological Properties of iPS-Derived NeuronsWhole-cell patch recordings from 12-week iPS-derived neurons from a non-alcohol dependent subject demonstrate functional neuronal properties, including generation of action potentials, spontaneous synaptic activity, and ionotropic receptor currents. (A) Neurons generate trains of action potentials in response to current injection. (B) Spontaneous synaptic activity (Inset) close-up of a spontaneous event demonstrates fast and slow kinetic components of the event. (C) GABA receptor current response to a 200 ms puff of 50μM GABA indicates that functional GABA receptors are present (arrow indicates when GABA was applied). (D) Depolarization response to a 200 ms puff of 50μM glutamate in the presence of Mg2+ indicates that functional AMPA receptors are expressed. Response was completely abolished when the AMPA antagonist DNQX (10µM) was perfused into the recording chamber (arrows indicate when glutamate was applied). (E) NMDA channel mediated depolarization in response to a 200 ms puff of 50μM glutamate and 10 μM glycine in a magnesium-free recording solution that contained the AMPA receptor antagonist DNQX (10µM). The response was completely abolished when NMDA receptor antagonist CPP (6µM) was perfused into the recording chamber (Dashed arrows indicate when glutamate plus glycine solution was applied).
Acute Alcohol Attenuation of NMDA Response is Not Observed After 7-Days of Alcohol ExposureWhole-cell patch clamp recordings from neurons derived from a non-alcohol dependent subject. (A) Example of the time course illustrating the inhibition of the NMDA response by acute alcohol exposure (50 mM) in a naïve neuron. (B) Example of the lack of effect of alcohol on NMDA receptors following 7-day exposure to 50 mM alcohol. (C) Group data for the effect of acute alcohol which significantly reduced the amplitude of the NMDA response (n=8, paired t-test, p= .036). (D) Group data for 7-day alcohol pre-treated cells showing no significant effect of bath applied alcohol on NMDA response (n=10, paired t-test, p= .77). Differences in the mean amplitude of the baseline depolarization between naïve and chronically treated cells (panels C and D) relate in large measure to variation in the distance of the puffing pipette from the patched cells examined.
NMDA Receptor Subunits are Upregulated After Chronic Alcohol Exposure in Neural Cells Derived from AlcoholicsNeural cells (age 12–15 weeks) derived from 7 different subjects, 3 non-alcoholics and 4 alcoholics, were treated daily with 50 mM alcohol for 7 days and levels of GRIN1, GRIN2A, GRIN2B, and GRIN2D mRNA expression was analyzed using RT-PCR. No significant changes were observed in the expression of these NMDA receptor subunit genes after 7-day alcohol exposure (relative to the sham condition) in neural cells derived from the group of non-alcoholic donor subjects (left group of data panels A–D). In contrast significant increases in mRNA levels compared to the sham condition were seen for neural cells derived from the alcoholic subject group for NMDA subunit genes (A) GRIN1, (B) GRIN2A, and (D) GRIN2D, while a trend towards significance was observed for (C) GRIN2B (p=0.06). Scatter plot symbols represent results from individual culture wells together with mean and SEM (significance level compared with sham condition * < 0.05, ** <0.01, *** <0.001).
Variability Between Subjects in NMDA Subunit mRNA changes following Alcohol Exposure and WithdrawalIndividual subject data normalized to each subject’s average sham NMDA receptor gene expression normalized to GUSB. iPS-derived neural cells from non-alcohol dependent (Non-AD) subjects are indicated on the left side of the x-axis, while neural cell generated from alcohol-dependent (AD) subjects are indicated on the right. Only one non-AD subject demonstrated an increase in NMDA mRNA expression following 7 days of alcohol exposure. In contrast, under these conditions, all four AD subjects demonstrated increased expression of GRIN1, which returned to baseline levels in three of the four subjects. Three AD subjects demonstrated increased GRIN2A expression, which continued to increase after 24 hours of withdrawal in all three subjects. Two AD subjects showed increases in GRIN2B and GRIN2D expression; with the exception of GRIN2B in one AD subject, these changes returned to baseline after withdrawal. (Symbols: open bars − sham condition; solid bars − 7-day of alcohol exposure; gray bars − 7-day alcohol + 24-hour withdrawal; error bars represent SEM).
| Name | Type |
|---|---|
| acamprosate | drug |
| aCSF | drug |
| action potential firing | phenotype |
| acute tolerance | phenotype |
| acute withdrawal | phenotype |
| AD donor subjects local | cohort |
| alcohol | phenotype |
| alcohol abuse | phenotype |
| alcohol dependence | phenotype |
| Alcoholic with cirrhosis local | phenotype |
| Alcoholic without co-morbid disease local | phenotype |
| alcoholism | phenotype |
| alcohol tolerance | phenotype |
| Alcohol Use Disorder | phenotype |
| alcohol use disorders | phenotype |
| ALCOHOL_USE_DISORDERS local | phenotype |
| alcohol withdrawal | phenotype |
| ALCOHOL_WITHDRAWAL local | phenotype |
| Alexa Fluor 488 | drug |
| Alexa Fluor 594 | drug |
| AMPA | drug |
| AMPA receptor | drug |
| AMPA receptor response local | phenotype |
| AMPA response local | phenotype |
| amygdala | anatomy |
| amyotrophic lateral sclerosis | phenotype |
| Angelman syndrome | phenotype |
| animal models | cohort |
| ascorbic acid | drug |
| B27 supplement | drug |
| basic fibroblast growth factor | drug |
| Bdnf | gene |
| beta III-tubulin local | phenotype |
| bFGF | drug |
| bovine serum albumin | drug |
| CaCl2 | drug |
| calcium | drug |
| cDNA | drug |
| central nervous system | anatomy |
| chronic alcoholism | phenotype |
| Chronic ethanol-treated neural cultures local | cohort |
| CNS hyperexcitability | phenotype |
| Control neural cultures local | cohort |
| controls | cohort |
| cortex | anatomy |
| CPP local | drug |
| dextrose | drug |
| dibutyryl-cAMP local | drug |
| dispase | drug |
| disulfiram | drug |
| DMEM/F12 | drug |
| DNQX | drug |
| DSM-IV alcohol dependence | phenotype |
| Dulbecco’s Modified Eagle Medium with F12 local | drug |
| EGTA | drug |
| embryoid bodies | phenotype |
| ethanol consumption | phenotype |
| excitatory post-synaptic potentials (EPSPs) local | phenotype |
| excitotoxicity | phenotype |
| Fibroblast cell line 1 local | cohort |
| Fibroblast cell line 2 local | cohort |
| Fibroblast cell line 3 local | cohort |
| Fibroblast cell line 4 local | cohort |
| Fibroblast cell line 5 local | cohort |
| Fibroblast cell line 6 local | cohort |
| Fibroblast cell line 7 local | cohort |
| Fyn | gene |
| GABA | phenotype |
| GABAA receptor | drug |
| GABAA_RECEPTOR local | gene |
| GABAA receptor response local | phenotype |
| GABAA response local | phenotype |
| GABA response local | phenotype |
| GDNF | drug |
| Genetic markers of risk for alcohol dependence local | phenotype |
| glutamate | drug |
| GLUTAMATE_RECEPTOR local | gene |
| glutamine | drug |
| glycine | drug |
| GRIN1 | gene |
| GRIN2A | gene |
| GRIN2B | gene |
| GRIN2C | gene |
| GRIN2D | gene |
| GUSB | gene |
| heavy drinking | phenotype |
| heparin | drug |
| HEPES | drug |
| hES cell-derived neural cells local | cohort |
| hES cells local | cohort |
| High Capacity cDNA Reverse Transcription kit | drug |
| hippocampus | anatomy |
| human embryonic stem cell media local | drug |
| Human fibroblast cells local | phenotype |
| Human iPS-derived neural cells local | anatomy |
| Human iPS-derived neural cells local | cohort |
| Human iPS-derived neural cultures local | anatomy |
| human subjects | cohort |
| IGF local | drug |
| iPS cell colonies local | phenotype |
| iPS cells | cohort |
| iPS-derived neural cells local | cohort |
| iPS-derived neural cultures local | cohort |
| IPS_DERIVED_NEURAL_CULTURES local | cohort |
| iPS-derived neurons local | cohort |
| KCl | drug |
| K-gluconate | drug |
| Klf4 | gene |
| Knockout Serum Replacer local | drug |
| laminin | drug |
| LIN28A local | gene |
| long-term potentiation (LTP) | phenotype |
| magnesium | drug |
| matrigel | drug |
| Mg2+ | drug |
| MgCl2 | drug |
| MgCl2-6H2O local | drug |
| motor cortex | anatomy |
| mouse embryonic fibroblasts local | phenotype |
| Myc | gene |
| N2 supplement | drug |
| Na2-ATP local | drug |
| Na-GTP | drug |
| NaH2PO4 | drug |
| NaHCO3 | drug |
| NALTRXONE local | drug |
| Nanog | gene |
| neural cell culture local | cohort |
| neural cells local | phenotype |
| neural cultures local | anatomy |
| neural differentiation media local | drug |
| neural epithelial cells local | phenotype |
| neural induction media local | drug |
| neural tube-like rosettes local | phenotype |
| neurite projections local | phenotype |
| neuroactive steroids | drug |
| neurobasal medium | drug |
| neurotransmitters | drug |
| NMDA | drug |
| NMDA receptor | drug |
| NMDA receptor activity local | phenotype |
| NMDA receptor function local | phenotype |
| NMDA receptor subunit local | gene |
| NMDA receptor subunit mRNA expression local | phenotype |
| NMDA response local | phenotype |
| NMDA subunit mRNA expression local | phenotype |
| Non-alcohol dependent social drinker local | phenotype |
| non-alcohol dependent subjects local | cohort |
| Non-alcoholic control local | phenotype |
| non-alcoholic subject local | cohort |
| Non-alcoholic subjects local | cohort |
| non-drinkers | phenotype |
| non-essential amino acids | drug |
| OPIOID_RECEPTOR local | gene |
| paraformaldehyde | drug |
| Parkinson’s disease | phenotype |
| phosphocreatine | drug |
| polyornithine | drug |
| Post-mortem human brain tissue local | cohort |
| POU5F1 | gene |
| Prader-Willi syndrome | phenotype |
| pyramidal-shaped soma local | phenotype |
| resting membrane potential -50 to -60 mV local | phenotype |
| RNA | drug |
| S100B local | gene |
| s100β local | phenotype |
| Sox2 | gene |
| spinal muscular atrophy | phenotype |
| spontaneous synaptic activity local | phenotype |
| SSEA-3 local | phenotype |
| SSEA-4 local | phenotype |
| superior frontal cortex | anatomy |
| SYN1 | gene |
| synapsin1 local | phenotype |
| topiramate | drug |
| Trizol reagent | drug |
| TUBB3 | gene |
| UCHC Stem Cell Core local | cohort |
| University of Connecticut Health Center (UCHC) local | cohort |
| US population | cohort |
| withdrawal | phenotype |
| β-mercaptoethanol | drug |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Uncovering NMDA receptor-mediated high firing activity in excitatory human neurons. | Gameiro-Ros I et al. | — | 2026 | → |
| Current Applications of Human Pluripotent Stem Cells in Neuroscience Research and Cell Transplantation Therapy for Neurological Disorders. | Verma I et al. | — | 2025 | → |
| Dynamic regulation of CeA gene expression during acute and protracted abstinence from chronic binge drinking of male and female C57BL/6J mice | Méndez HG et al. | — | 2024 | — |
| Dynamic regulation of CeA gene expression during acute and protracted abstinence from chronic binge drinking of male and female C57BL/6J mice. | Méndez HG et al. | — | 2024 | → |
| Human pluripotent stem cells as a translational toolkit in psychedelic research <i>in vitro</i>. | Salerno JA et al. | — | 2024 | → |
| Polygenic risk for alcohol use disorder affects cellular responses to ethanol exposure in a human microglial cell model. | Li X et al. | — | 2024 | → |
| Upregulated GIRK2 Counteracts Ethanol-Induced Changes in Excitability and Respiration in Human Neurons. | Prytkova I et al. | — | 2024 | → |
| 5. Collaborative Study on the Genetics of Alcoholism: Functional genomics. | Gameiro-Ros I et al. | — | 2023 | → |
| Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. | Popova D et al. | — | 2023 | → |
| A functional hiPSC-cortical neuron differentiation and maturation model and its application to neurological disorders. | Autar K et al. | — | 2022 | → |
| Targeting NMDA receptors in neuropsychiatric disorders by drug screening on human neurons derived from pluripotent stem cells. | Zhang W et al. | — | 2022 | → |
| Robust Expression of Functional NMDA Receptors in Human Induced Pluripotent Stem Cell-Derived Neuronal Cultures Using an Accelerated Protocol. | Ruden JB et al. | — | 2021 | → |
| Assessment of Ethanol-Induced Toxicity on iPSC-Derived Human Neurons Using a Novel High-Throughput Mitochondrial Neuronal Health (MNH) Assay. | Zink A et al. | — | 2020 | → |
| Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. | Scarnati MS et al. | — | 2020 | → |
| Induced pluripotent stem cell reprogramming-associated methylation at the GABRA2 promoter and chr4p12 GABA<sub>A</sub> subunit gene expression in the context of alcohol use disorder. | Goetjen A et al. | — | 2020 | → |
| Mental health dished up-the use of iPSC models in neuropsychiatric research. | McNeill RV et al. | — | 2020 | → |
| Molecular Correlates of Topiramate and GRIK1 rs2832407 Genotype in Pluripotent Stem Cell-Derived Neural Cultures. | Lieberman R et al. | — | 2020 | → |
| Alcohol-responsive genes identified in human iPSC-derived neural cultures. | Jensen KP et al. | — | 2019 | → |
| Early Actions of Neurotransmitters During Cortex Development and Maturation of Reprogrammed Neurons. | Ojeda J et al. | — | 2019 | → |
| Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells. | Di Rocco G et al. | — | 2019 | → |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | — | 2019 | → |
| Examining the effects of alcohol on GABA<sub>A</sub> receptor mRNA expression and function in neural cultures generated from control and alcohol dependent donor induced pluripotent stem cells. | Lieberman R et al. | — | 2018 | → |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | — | 2018 | → |
| Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders. | Fink JJ et al. | — | 2018 | → |
| Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells. | Fink JJ et al. | — | 2017 | → |
| Examining FKBP5 mRNA expression in human iPSC-derived neural cells. | Lieberman R et al. | — | 2017 | → |
| Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells. | De Filippis L et al. | — | 2016 | → |
| Fyn Kinase regulates GluN2B subunit-dominant NMDA receptors in human induced pluripotent stem cell-derived neurons. | Zhang WB et al. | — | 2016 | → |
| N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development. | Bagasrawala I et al. | — | 2016 | → |
| Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics. | Sheng Y et al. | — | 2016 | → |
| Advances in Medications and Tailoring Treatment for Alcohol Use Disorder. | Seneviratne C et al. | — | 2015 | → |
| Ethanol upregulates NMDA receptor subunit gene expression in human embryonic stem cell-derived cortical neurons. | Xiang Y et al. | — | 2015 | → |
| GABRA2 Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAA Subunit Genes in Human Neural Cultures. | Lieberman R et al. | — | 2015 | → |
| Time- and dose-dependent effects of ethanol on mouse embryonic stem cells. | Worley SL et al. | — | 2015 | → |
| Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1. | Germain ND et al. | — | 2014 | → |
| The Genetics, Neurogenetics and Pharmacogenetics of Addiction. | Demers CH et al. | — | 2014 | → |
| A systems medicine research approach for studying alcohol addiction. | Spanagel R et al. | — | 2013 | → |
| Glutamatergic targets for new alcohol medications. | Holmes A et al. | — | 2013 | → |
| Developmental neurotoxicity screening using human embryonic stem cells. | Bosnjak ZJ | — | 2012 | → |